Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,631 | 1 | 40.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,041 | 2 | 33.6% |
| Food and Beverage | $1,431 | 20 | 15.8% |
| Travel and Lodging | $773.17 | 2 | 8.5% |
| Education | $186.73 | 4 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $4,183 | 11 | $0 (2020) |
| Outset Medical Inc | $3,631 | 1 | $0 (2023) |
| Amgen Inc. | $299.59 | 4 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $204.17 | 2 | $0 (2019) |
| BAXTER HEALTHCARE | $202.03 | 3 | $0 (2019) |
| NxStage Medical, Inc. | $146.64 | 3 | $0 (2019) |
| Horizon Pharma plc | $103.59 | 1 | $0 (2018) |
| Mallinckrodt LLC | $99.99 | 1 | $0 (2018) |
| Relypsa, Inc. | $89.74 | 1 | $0 (2017) |
| Veloxis Pharmaceuticals, Inc. | $82.38 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $3,631 | 1 | Outset Medical Inc ($3,631) |
| 2020 | $4,136 | 10 | Otsuka America Pharmaceutical, Inc. ($4,035) |
| 2019 | $438.57 | 7 | Alexion Pharmaceuticals, Inc. ($204.17) |
| 2018 | $452.54 | 6 | Horizon Pharma plc ($103.59) |
| 2017 | $404.63 | 5 | BAXTER HEALTHCARE ($125.00) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2023 | Outset Medical Inc | — | Consulting Fee | Cash or cash equivalent | $3,630.64 | General |
| 03/25/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,767.00 | General |
| Category: NEPHROLOGY | ||||||
| 03/25/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $274.00 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $52.70 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: NEPHROLOGY | ||||||
| 02/28/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | In-kind items and services | $491.80 | General |
| Category: NEPHROLOGY | ||||||
| 02/28/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | In-kind items and services | $281.37 | General |
| Category: NEPHROLOGY | ||||||
| 02/28/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $111.97 | General |
| Category: NEPHROLOGY | ||||||
| 02/13/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $100.76 | General |
| Category: Nephrology | ||||||
| 10/31/2019 | BAXTER HEALTHCARE | Renal - CRRT (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Renal | ||||||
| 10/30/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 09/19/2019 | NxStage Medical, Inc. | — | Food and Beverage | In-kind items and services | $45.87 | General |
| 09/18/2019 | NxStage Medical, Inc. | — | Food and Beverage | In-kind items and services | $27.21 | General |
| 06/19/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 05/29/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $79.17 | General |
| 04/11/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $86.13 | General |
| Category: NEPHROLOGY | ||||||
| 12/04/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 11/15/2018 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Education | In-kind items and services | $21.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2018 | BAXTER HEALTHCARE | Renal - Non Product Related (Biological) | Food and Beverage | In-kind items and services | $63.04 | General |
| Category: Renal | ||||||
| 05/15/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $82.38 | General |
| Category: Immunosuppressant | ||||||
| 03/14/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $82.50 | General |
| Category: Nephrology | ||||||
| 03/07/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | Cash or cash equivalent | $103.59 | General |
| Category: KRYSTEXXA | ||||||
| 10/11/2017 | Amgen Inc. | — | Education | In-kind items and services | $4.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 509 | 929 | $602,318 | $136,670 |
| 2022 | 11 | 477 | 920 | $560,698 | $130,228 |
| 2021 | 12 | 535 | 903 | $304,313 | $120,745 |
| 2020 | 17 | 1,095 | 3,248 | $1.1M | $179,177 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 44 | 204 | $242,556 | $54,779 | 22.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 41 | 103 | $101,661 | $22,788 | 22.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 11 | 54 | $49,410 | $11,698 | 23.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 121 | $48,410 | $11,002 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 113 | 147 | $30,409 | $9,836 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 38 | 61 | $17,083 | $6,109 | 35.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 45 | $33,801 | $5,942 | 17.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $9,854 | $3,317 | 33.7% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 15 | 18 | $13,680 | $2,790 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 53 | 62 | $8,897 | $2,716 | 30.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 28 | 43 | $33,325 | $2,356 | 7.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 27 | 27 | $8,100 | $2,248 | 27.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 18 | $5,132 | $1,089 | 21.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 43 | 222 | $255,078 | $60,167 | 23.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 41 | 104 | $98,908 | $23,694 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 96 | 138 | $28,374 | $9,190 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 49 | 86 | $23,320 | $9,126 | 39.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 110 | $44,110 | $8,430 | 19.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 32 | $24,032 | $4,840 | 20.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 30 | 66 | $49,500 | $3,707 | 7.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 27 | 27 | $10,233 | $3,647 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 70 | 77 | $10,164 | $3,458 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 25 | 25 | $7,475 | $2,181 | 29.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 33 | $9,504 | $1,787 | 18.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 46 | 189 | $67,002 | $52,601 | 78.5% |
About Dr. Arvind Garg, M.D
Dr. Arvind Garg, M.D is a Nephrology healthcare provider based in La Crosse, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2009. The National Provider Identifier (NPI) number assigned to this provider is 1154551968.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arvind Garg, M.D has received a total of $9,063 in payments from pharmaceutical and medical device companies, with $3,631 received in 2023. These payments were reported across 29 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($3,631).
As a Medicare-enrolled provider, Garg has provided services to 2,616 Medicare beneficiaries, totaling 6,000 services with total Medicare billing of $566,819. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology, Nephrology
- Location La Crosse, WI
- Active Since 07/15/2009
- Last Updated 06/06/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1154551968
Products in Payments
- JYNARQUE (Drug) $4,122
- Parsabiv (Biological) $194.33
- Renal - Non Product Related (Biological) $188.04
- SOLIRIS (Drug) $125.00
- KRYSTEXXA (Drug) $103.59
- Parsabiv (Drug) $100.76
- ACTHAR (Biological) $99.99
- Veltassa (Drug) $89.74
- Envarsus XR (SP) (Drug) $82.38
- System One (Device) $73.56
- SAMSCA (Drug) $61.20
- LOKELMA (Drug) $21.04
- Renal - CRRT (Device) $13.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in La Crosse
Thu Nguyen, Do, DO
Nephrology — Payments: $1,467
Dr. Kumari Usha, Md, MD
Nephrology — Payments: $371.89
Dr. Bashar Omari, Md, MD
Nephrology — Payments: $253.11
Paul Merchant, Md, MD
Nephrology — Payments: $187.54
Oscar Garcia Valencia, Md, MD
Nephrology — Payments: $99.99
Dr. Sumaiya Siddiqi, Md, MD
Nephrology — Payments: $99.36